PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Berman, Abigail
TI  - PT May Be Safer than PF Chemoradiotherapy for LAEC
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 15--16
VI  - 14
IP  - 31
4099  - http://mdc.sagepub.com/content/14/31/15.short
4100  - http://mdc.sagepub.com/content/14/31/15.full
AB  - Current neoadjuvant chemoradiation therapy (nCRT) for locally advanced esophageal cancer (LAEC) consists of radiation with platinum/5-FU (PF) chemotherapy. However, carboplatin/paclitaxel (PT) may be a favorable chemotherapy combination with preoperative radiation. The study discussed in this article investigated whether nCRT with PT would result in better perioperative outcomes.